Telesis BioTBIO
13F holders, Q2 2024 (June 30)10holders
1famous investor
$3.65avg. 13F price*
At the end of Q2 2024, 10 institutions reported holding Telesis Bio Inc. (TBIO) in their 13F filings. The largest holders were Northpond Ventures, LLC ($2.0M), Millennium Management ($47K) and UBS Group AG ($9K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Telesis Bio Inc.
- CUSIP
- 192003200
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $7 |
| Exits | 0 | $0 |
Ownership 10 holders
| Northpond Ventures, LLC | 3.61% | Reduce -2.4% | 546,897 | $2.0M |
| Millennium Management | 0.00% | Reduce -2.4% | 12,911 | $47K |
| UBS Group AG | 0.00% | Add +0.9% | 2,456 | $9K |
| Bank of America Corp. | 0.00% | Reduce -1.1% | 338 | $1K |
| Dynamic Wealth Strategies, LLC | 0.00% | Reduce -1.9% | 138 | $1K |
| JPMorgan Chase & Co. | 0.00% | Add +2.2% | 31 | $113 |
| Qube Research & Technologies Ltd | 0.00% | No change | 23 | $84 |
| BNP Paribas Financial Markets | 0.00% | New | 2 | $7 |
| Citigroup Inc. | 0.00% | Add +192.8% | 1 | $4 |
| Royal Bank of Canada | 0.00% | Add +231.9% | 24 | $0 |
"% of holder's portfolio" is TBIO's weight in each manager's 13F, not the share of Telesis Bio Inc. the manager owns.